Triumph Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33K Buy
129
+4
+3% +$984 0.01% 819
2026
Q2
$23.4K Hold
125
– – ﹤0.01% 895
2026
Q1
$23.6K Hold
125
– – ﹤0.01% 836
2025
Q4
$24.8K Buy
+125
New +$25.3K 0.01% 805

Other funds holding THC

Triumph Capital Management's THC Position: Q3 2026 in Review

Triumph Capital Management increased its Tenet Healthcare (THC) stake by 3.2% in Q3 2026, buying an estimated $984 and bringing the position to 129 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #819.

Triumph Capital Management first reported a position in THC in Q4 2025 and has held it in 4 quarters since. 366 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Triumph Capital Management held 129 shares of Tenet Healthcare worth $33K as of Q3 2026.
  • Triumph Capital Management bought 4 Tenet Healthcare shares in Q3 2026, an estimated $984.
  • Tenet Healthcare made up 0.01% of Triumph Capital Management's portfolio in Q3 2026, its #819 holding.
  • Triumph Capital Management first reported a position in Tenet Healthcare in Q4 2025 and has held it in 4 quarters since.
  • 366 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.